Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Fink-Jensen

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Ugeskrift for Laeger|July 28, 2016
[There is a need for a strengthened and unified treatment of dual diagnosis patients]Anders Fink-Jensen
Ugeskrift for Laeger|April 9, 2021
[Alcohol use disorders and comorbidity]Anders Fink-Jensen
Ugeskrift for Laeger|September 10, 2010
[Increase of the number of violent criminal psychiatric patients]Anders Fink-Jensen
Ugeskrift for Laeger|February 2, 2012
[Switching antipsychotics is often necessary but not uncomplicated]Anders Fink-Jensen
Ugeskrift for Laeger|March 26, 2010
[The genetic basis for mental diseases]Thomas Werge, Anders Fink-Jensen
Nordic Journal of Psychiatry|May 7, 2016
Glucagon-like peptide-1 (GLP-1) analogues: A potential new treatment for alcohol use disorder?Anders Fink-Jensen, Tina Vilsbøll
Ugeskrift for Laeger|May 9, 2008
[Involuntary commitment]Jeanett Bauer, Anders Fink-Jensen
Ugeskrift for Laeger|March 27, 2009
[Future psychiatry]Anders Fink-Jensen, Marianne Kastrup
Acta Psychiatrica Scandinavica|November 14, 2024
Letter to the Editor Concerning "Glucagon-Like Peptide Agonists for Weight Management in Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis"Anders Fink-Jensen, Christoph U Correll
Acta Psychiatrica Scandinavica|November 8, 2024
How to treat antipsychotic-related weight gain and metabolic disturbances: Is there a role for GLP-1 receptor agonists?Anders Fink-Jensen, Christoph U Correll
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Ugeskrift for Laeger|July 28, 2016
[There is a need for a strengthened and unified treatment of dual diagnosis patients]Anders Fink-Jensen
Ugeskrift for Laeger|April 9, 2021
[Alcohol use disorders and comorbidity]Anders Fink-Jensen
Ugeskrift for Laeger|September 10, 2010
[Increase of the number of violent criminal psychiatric patients]Anders Fink-Jensen
Ugeskrift for Laeger|February 2, 2012
[Switching antipsychotics is often necessary but not uncomplicated]Anders Fink-Jensen
Ugeskrift for Laeger|March 26, 2010
[The genetic basis for mental diseases]Thomas Werge, Anders Fink-Jensen
Nordic Journal of Psychiatry|May 7, 2016
Glucagon-like peptide-1 (GLP-1) analogues: A potential new treatment for alcohol use disorder?Anders Fink-Jensen, Tina Vilsbøll
Ugeskrift for Laeger|May 9, 2008
[Involuntary commitment]Jeanett Bauer, Anders Fink-Jensen
Ugeskrift for Laeger|March 27, 2009
[Future psychiatry]Anders Fink-Jensen, Marianne Kastrup
Acta Psychiatrica Scandinavica|November 14, 2024
Letter to the Editor Concerning "Glucagon-Like Peptide Agonists for Weight Management in Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis"Anders Fink-Jensen, Christoph U Correll
Acta Psychiatrica Scandinavica|November 8, 2024
How to treat antipsychotic-related weight gain and metabolic disturbances: Is there a role for GLP-1 receptor agonists?Anders Fink-Jensen, Christoph U Correll
Pageof 15